For the fourth time, Midas Pharma employees participated in the annual charity run for a good cause. Colleagues around the world ran, swam or cycled to collect kilometres, which were rewarded by the company with donations. Over 9,000 kilometres were collected in this way. The resulting donation amount of €15,000 will now benefit three pre-selected projects in Brazil, India and the Ahrtal.
The new NIS 2 directive presents new challenges, but also opportunities for the Midas Group. This article provides an overview of how the company is preparing for increased cybersecurity requirements while raising awareness among its employees.
At Bio International Convention in San Diego, US the Midas Biotech- and Services-Team will present its Portfolio of Biotech Services as shown below.
The Midas group, headquartered in Ingelheim am Rhein, looks back at three decades of successful business in the international chemical and pharmaceutical industry. With around 300 employees at ten locations worldwide, the company has continuously expanded its expertise in the fields of fine chemicals, industrial chemicals, custom synthesis and technology transfer. In 2023, the Midas group generated a turnover of about 550 million EUR.
In a recently published article standard cartridge primary packaging material of five different companies were analyzed for their behavior under long-term pressure. Materials of 3 glass manufacturers and 2 manufacturers for cartridge rubber parts were considered. In addition to the influence of permanent pressure on material stability, the stability of an approved and marketed antibody drug was also investigated as part of the extensive test programme.
Midas employees therefore ran, hiked, swam or cycled this distance together.
The new setup allows to become more active in the field of In- and Outlicensing of many pharmaceutical products, like Excipients, Intermediates, APIs and Final Dosage Forms. In particular, the new status allows Midas China to be a competent point of contact towards the Chinese Authorities, to perform more and more registration activities with the CDE (Chinese Center for Drug Evaluation).
It will be the 41st edition of the Pharma-Cup, an indoor soccer tournament among German pharmaceutical companies, in which the team of Midas will participate on March 23, 2024. The venue this year will take place in Blaustein close to the city of Ulm and hosted by Teva Ratiopharm, the defending champion of last year. CSL Behring, and Teva Ratiopharm is the title defender.
Together with the Live Directors team and with the support of many nice colleagues, we managed to give an insight into the company and everyday working life at Midas Pharma in just 60 seconds. The special thing about this video: none of our employees who agreed to be interviewed knew the questions they were asked that day.
New Publication on the Gx Inbeneo® Platform Simulator